Technical Analysis for LMNX - Luminex Corporation

Grade Last Price % Change Price Change
B 31.59 -2.86% -0.93
LMNX closed down 2.86 percent on Monday, March 1, 2021, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical LMNX trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup -2.86%
Calm After Storm Range Contraction -2.86%
Upper Bollinger Band Walk Strength -2.86%
Inside Day Range Contraction -2.86%
Above Upper BB Strength -2.86%
Older End-of-Day Signals for LMNX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 8 hours ago
Down 2 % about 10 hours ago
Up 1% about 11 hours ago
Down 1% about 11 hours ago
Fell Below Upper Bollinger Band about 11 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Luminex Corporation Description

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment's products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company's proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Life Sciences Pharmaceutical Acid Chemical Natural Sciences Genetics Optics Robotics Multiplex Acids Infectious Disease Multiplexing Signal Processing Companion Diagnostic Styrene Genetic Testing Digital Signal Processing Laboratory Techniques Nucleic Acids Polymerase Chain Reaction Personalized Medicine Fluidics Luminex Corporation Real Time Polymerase Chain Reaction Testing Technologies

Is LMNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.69
52 Week Low 20.61
Average Volume 589,106
200-Day Moving Average 27.80
50-Day Moving Average 27.24
20-Day Moving Average 29.25
10-Day Moving Average 29.83
Average True Range 1.85
ADX 26.61
+DI 32.04
-DI 16.69
Chandelier Exit (Long, 3 ATRs ) 29.52
Chandelier Exit (Short, 3 ATRs ) 30.37
Upper Bollinger Band 32.49
Lower Bollinger Band 26.02
Percent B (%b) 0.86
BandWidth 22.11
MACD Line 1.06
MACD Signal Line 0.77
MACD Histogram 0.2904
Fundamentals Value
Market Cap 1.47 Billion
Num Shares 46.5 Million
EPS 0.40
Price-to-Earnings (P/E) Ratio 79.37
Price-to-Sales 2.66
Price-to-Book 2.09
PEG Ratio 0.70
Dividend 0.36
Dividend Yield 1.14%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.53
Resistance 3 (R3) 33.73 33.29 33.20
Resistance 2 (R2) 33.29 32.80 33.19 33.09
Resistance 1 (R1) 32.44 32.49 32.22 32.24 32.99
Pivot Point 32.00 32.00 31.89 31.90 32.00
Support 1 (S1) 31.15 31.51 30.93 30.95 30.19
Support 2 (S2) 30.71 31.20 30.61 30.09
Support 3 (S3) 29.86 30.71 29.98
Support 4 (S4) 29.66